{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-087347","form_type":"8-K","ticker":"SEM","cik":"0001320414","company_name":"SELECT MEDICAL HOLDINGS CORP","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.557142+00:00","generated_at":"2026-06-12T07:26:42.628131+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Select Medical Q2 EPS $0.61 (+44% YoY), revenue up 5.7%; declares $0.125 dividend","bullets":["Q2 revenue $1,674.5M (+5.7% YoY); net income $91.9M (+38.6% YoY); Adjusted EBITDA $219.5M (+21.3% YoY).","Critical illness recovery hospital segment Adjusted EBITDA surged 227% to $65.5M; margin 11.4% vs 3.7%.","Board declared $0.125/share cash dividend, payable Sep 1, 2023 to holders of record Aug 15.","FY2023 outlook: revenue $6.55-6.7B, Adjusted EBITDA $795-825M, EPS $1.77-1.94, adjusted EPS $1.86-2.03.","No shares repurchased in H1 2023; $1.0B buyback program expires Dec 31, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-087347","json":"https://secwatch.observer/filing/0001104659-23-087347.json","markdown":"https://secwatch.observer/filing/0001104659-23-087347.md","text":"https://secwatch.observer/filing/0001104659-23-087347.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1320414/000110465923087347/0001104659-23-087347-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1320414/000110465923087347/tm2322751d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T07:26:42.628131+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"93244c93375236920ed35280b7a1cafcd6b8b85e","claim":"SELECT MEDICAL HOLDINGS CORP reported second quarter ended June 30, 2023 results: revenue $1,674.5 million, net income $91.9 million, EPS $0.61.","evidence_excerpt":"For the second quarter ended June 30, 2023, revenue increased 5.7% to $1,674.5 million, compared to $1,584.7 million for the same quarter, prior year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1320414/000110465923087347/0001104659-23-087347-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$1,674.5 million"},{"label":"Net income","value":"$91.9 million"},{"label":"EPS","value":"$0.61"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}